Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine versus mepivacaine for inferior alveolar nerve block in bilateral impacted mandibular third molar removal
IRCT20170307032929N2Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of articaine and mepivacaine in Impacted lower third molar (2 arms), sponsored by Islamic Azad University. Primary endpoints: Onset time of anesthesia and Pain during extraction. Started Sep 2019; status: completed.
02
Drugs
articainemepivacaine
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on IRCT20170307032929N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170307032929N2.